Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL141P, also known as RNA, 7SL, cytoplasmic 141, pseudogene, is a non-coding RNA pseudogene related to the 7SL RNA gene, which normally codes for the RNA portion of the signal recognition particle (SRP)[1][2][5]. The majority of 7SL RNA-related sequences dispersed throughout the human genome are pseudogenes, formed either by retrotransposition or genetic recombination events, and do not code for functional RNA or proteins[1][2]. RN7SL141P does not have proven biological function, nor is it known to play a role in disease pathology or serve as a biomarker. As a pseudogene, it may complicate molecular genetic analysis due to sequence similarity with the functional 7SL RNA gene, but is not regarded as a target for therapeutic development[1][2][6][7].
None applicable. There is no established drug mechanism of action involving RN7SL141P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 141, pseudogene (RN7SL141P).